These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9125432)

  • 1. Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine.
    Hoshi K; Ma T; Oh S; Ho IK
    Brain Res; 1997 Apr; 753(1):63-8. PubMed ID: 9125432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precipitated kappa-opioid receptor agonist withdrawal increase glutamate in rat locus coeruleus.
    Hoshi K; Ma T; Ho IK
    Eur J Pharmacol; 1996 Oct; 314(3):301-6. PubMed ID: 8957250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats.
    Feng Y; Rockhold RW; Ho IK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):932-8. PubMed ID: 9353416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
    Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK
    Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats.
    Tokuyama S; Zhu H; Wakabayashi H; Feng YZ; Ho IK
    J Biomed Sci; 1998; 5(1):45-53. PubMed ID: 9570513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids.
    Tokuyama S; Zhu H; Oh S; Ho IK; Yamamoto T
    Neurochem Int; 2001 Aug; 39(2):103-9. PubMed ID: 11408088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nor-binaltorphimine on butorphanol dependence.
    Jaw SP; Makimura M; Hoskins B; Ho IK
    Eur J Pharmacol; 1993 Aug; 239(1-3):133-40. PubMed ID: 8223888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
    Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK
    Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitatory amino acid release in the locus coeruleus during naloxone-precipitated morphine withdrawal in adjuvant arthritic rats.
    Hoshi K; Yamamoto A; Ishizuki S; Fujihira E; Ichihara K
    Inflamm Res; 2000 Jan; 49(1):36-41. PubMed ID: 10778919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat.
    Feng YZ; Zhang T; Rockhold RW; Ho IK
    Neurochem Res; 1995 Jun; 20(6):745-51. PubMed ID: 7566372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats.
    Tokuyama S; Ho IK
    Brain Res; 1996 May; 722(1-2):212-6. PubMed ID: 8813371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat.
    Zhang T; Feng Y; Rockhold RW; Ho IK
    Life Sci; 1994; 55(2):PL25-31. PubMed ID: 7912397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
    Sullivan ME; Hall SR; Milne B; Jhamandas K
    Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
    Jewett DC; Grace MK; Jones RM; Billington CJ; Portoghese PS; Levine AS
    Brain Res; 2001 Aug; 909(1-2):75-80. PubMed ID: 11478923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine.
    Wongchanapai W; Tsang BK; He Z; Ho IK
    Pharmacol Biochem Behav; 1998 Aug; 60(4):899-907. PubMed ID: 9700974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
    Craft RM; McNiel DM
    Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
    Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
    Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced binding of nor-binaltorphimine to kappa-opioid receptors in rats dependent on butorphanol.
    Fan LW; Tien LT; Tanaka S; Sasaki K; Park Y; Ma T; Rockhold RW; Ho IK
    J Neurosci Res; 2003 Jun; 72(6):781-9. PubMed ID: 12774318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.